Related Experiment Videos
The three-dimensional structure of shikimate kinase
T Krell1, J R Coggins, A J Lapthorn
1Department of Chemistry, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
Journal of Molecular Biology
|June 20, 1998
Summary
Structural analysis of shikimate kinase from Erwinia chrysanthemi reveals major conformational changes upon ligand binding. This enzyme shares structural similarities with adenylate kinase, offering insights into substrate binding mechanisms.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Shikimate kinase (EcSK) is crucial in the shikimate pathway, essential for synthesizing aromatic amino acids in bacteria.
- Understanding the three-dimensional structure of EcSK provides insights into its catalytic mechanism and potential drug targets.
Purpose of the Study:
- To determine the high-resolution three-dimensional structure of shikimate kinase from Erwinia chrysanthemi.
- To elucidate the enzyme's conformational changes upon ligand binding and compare its structure to related enzymes.
Main Methods:
- X-ray crystallography using multiple isomorphous replacement.
- Determination of two models: a 1.9 Å high-resolution model and a 2.6 Å model with bound Mg-ADP.
- Difference Fourier calculations to identify ligand-binding sites.
Main Results:
- The structure reveals an α/β protein with topology similar to adenylate kinase, featuring a P-loop core and flexible domains.
- Major conformational changes and induced fit movements were observed upon ligand binding.
- Identified a distinct Mg2+ binding mode and characterized the adenine-binding motif (I/VDAXQ/NXP).
- The shikimate binding site was mapped to the location of the AMP-binding site in adenylate kinase.
Conclusions:
- Shikimate kinase exhibits significant structural plasticity, undergoing induced fit upon substrate binding.
- Structural comparisons with adenylate kinase highlight conserved and divergent features in enzyme active sites.
- The determined structure provides a foundation for understanding shikimate kinase function and designing inhibitors.